Bookmark and Share

BioActivity Data for Compound Glucose (CID 5793)

BioActivity Outcomes:
Active(1)
 
 
Inactive(189)
 
 
Inconclusive(5)
 
 
Unspecified(49)
 
 
Top Targets:
NR LBD ER(14)
 
 
NR LBD AR(14)
 
 
NR LBD PPAR(10)
 
 
NR LBD TR(8)
 
 
NR LBD GR(8)
 
 
BioAssay Types:
Confirmatory(143)
 
 
 
Literature(47)
 
 
 
Summary(41)
 
 
Screening(7)
 
 
BioAssay Categories:
In vitro(2)
 
 
In vivo(1)
 
 
Biochemical(21)
 
 
Toxicity(12)
 
 
ADME(9)
 
 
Cell-based(7)
 
 
BioActivity Types:
Potency(176)
 
 
 
Ki(6)
 
 
IC50(4)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 178    Data Row: 244   Total Pages: 13   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID48415870]
DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other]
View
2
[SID104243011]
IC50 30Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins [AID377830, Type: Literature]
View
3
[SID104243011]
IC50 30Antioxidant activity assessed as authentic peroxynitrite free radical scavenging activity after 30 mins [AID377831, Type: Literature]
View
4
[SID104243011]
IC50 30Antioxidant activity assessed as 3-morpholinosydnonimine-derived peroxynitrite free radical scavenging activity after 30 mins [AID377832, Type: Literature]
View
5
[SID104243011]
Ki 1698.24Inhibitory activity against glycogen phosphorylase, activity expressed as -logKi [AID73810, Type: Literature]
View
6
[SID104243011]
Ki 1698.24Affinity on glycogen phosphorylase (GP) enzyme. [AID73821, Type: Literature]
View
7
[SID104243011]
Ki 1700Inhibition of rabbit glycogen phosphorylase B enzyme [AID73815, Type: Literature]
View
8
[SID104243011]
Ki 1700The compound was evaluated for the inhibition of glycogen phosphorylase [AID73819, Type: Literature]
View
9
[SID104243011]
Ki 7400Inhibitory binding constant against glycogen phosphorylase B [AID73826, Type: Literature]
View
10
[SID104243011]
Ki 7400Inhibitory activity against muscle Glycogen Phosphorylase b [AID141119, Type: Literature]
View
11
[SID104243011]
IC50 500000Inhibition of Cryptosporidium parvum recombinant Galactose/N-acetylgalactosamine-specific lectin binding to Caco2A cells [AID381596, Type: Literature]
View
12
[SID104243011]
Inhibition of Cryptosporidium parvum recombinant Galactose/N-acetylgalactosamine-specific lectin binding to Caco2A cells relative to galactose [AID381597, Type: Literature]
View
13
[SID104243011]
Activation of AMPKalpha in rat L6 cells assessed as ATP concentration per mg of protein at 5 mM [AID389773, Type: Literature]
View
14
[SID104243011]
Activation of AMPKalpha in rat L6 cells assessed as ATP concentration per mg of protein at 23 mM [AID389774, Type: Literature]
View
15
[SID104243011]
Duration of spinal anesthesia at the digits of the hind limbs was measured in sheep at dose 40(mg/kg) [AID204254, Type: Literature]
View
16
[SID104243011]
Duration of spinal anesthesia at the weight support was measured in sheep at dose 40(mg/kg) [AID204259, Type: Literature]
View
17
[SID104243011]
Ratio of catalytic constant (kcat)/Kinetic constant(Km) [AID226604, Type: Literature]
View
18
[SID104243011]
Binding energy by using the equation deltaG obsd = -RT ln KD [AID227718, Type: Literature]
View
19
[SID104243011]
Hypoglycemic activity in Rattus norvegicus (rat) INS1 cells assessed as insulin release at 5.6 mmol/l after 90 min (Rvb = 62.96 +/- 5.68 to 69.70 +/- 4.98 %) [AID1094867, Type: other]
View
20
[SID104243011]
Insulinotropic activity in Rattus norvegicus (rat) INS-1 cells assessed as increase of glucose-induced insulin release at 3 mM after 90 min by radioimmunoassay relative to 5.6 mM of glucose [AID1094673, Type: other]
View